Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Redfield

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
JAMA|October 28, 2010
Long-term nonprogressive disease among individuals with untreated HIV infectionMohammad Sajadi, Robert R Redfield
Transplantation|December 14, 2011
Progression of monoclonal gammopathy of undetermined significance to multiple myeloma in a solid organ transplantRobert R Redfield, Ali Naji
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2008
Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapineRobert R Redfield, J Scott Morrow
Cell Research|December 16, 2005
Approaches to antiretroviral therapy in ChinaBruce L Gilliam, Robert R Redfield
Current Topics in Medicinal Chemistry|October 8, 2003
Therapeutic HIV vaccinesBruce L Gilliam, Robert R Redfield
HIV/AIDS (Auckland, N.Z.)|February 21, 2012
The use of preexposure treatments for HIV prophylaxisAdrian Majid, Robert R Redfield, Bruce L Gilliam
AIDS (London, England)|August 24, 2004
Improving on success: what treating the urban poor in America can teach us about improving antiretroviral programmes in AfricaAnthony Amoroso, Derek E Spencer, Robert R Redfield
Pediatrics|January 19, 2019
Public Health Surveillance of Prenatal Opioid Exposure in Mothers and InfantsMargaret A Honein, Coleen Boyle, Robert R Redfield
AIDS (London, England)|May 11, 2013
Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infectionMohammad M Sajadi, Robert R Redfield, Rohit Talwani
Journal of Translational Medicine|February 3, 2011
Clinical use of CCR5 inhibitors in HIV and beyondBruce L Gilliam, David J Riedel, Robert R Redfield
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
JAMA|October 28, 2010
Long-term nonprogressive disease among individuals with untreated HIV infectionMohammad Sajadi, Robert R Redfield
Transplantation|December 14, 2011
Progression of monoclonal gammopathy of undetermined significance to multiple myeloma in a solid organ transplantRobert R Redfield, Ali Naji
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2008
Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapineRobert R Redfield, J Scott Morrow
Cell Research|December 16, 2005
Approaches to antiretroviral therapy in ChinaBruce L Gilliam, Robert R Redfield
Current Topics in Medicinal Chemistry|October 8, 2003
Therapeutic HIV vaccinesBruce L Gilliam, Robert R Redfield
HIV/AIDS (Auckland, N.Z.)|February 21, 2012
The use of preexposure treatments for HIV prophylaxisAdrian Majid, Robert R Redfield, Bruce L Gilliam
AIDS (London, England)|August 24, 2004
Improving on success: what treating the urban poor in America can teach us about improving antiretroviral programmes in AfricaAnthony Amoroso, Derek E Spencer, Robert R Redfield
Pediatrics|January 19, 2019
Public Health Surveillance of Prenatal Opioid Exposure in Mothers and InfantsMargaret A Honein, Coleen Boyle, Robert R Redfield
AIDS (London, England)|May 11, 2013
Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infectionMohammad M Sajadi, Robert R Redfield, Rohit Talwani
Journal of Translational Medicine|February 3, 2011
Clinical use of CCR5 inhibitors in HIV and beyondBruce L Gilliam, David J Riedel, Robert R Redfield
Pageof 20